Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age In this role Joined 2024 pay Source
Steven Lewis Dyson
Chief Executive Officer
Title from the Form 3 dated Aug 18, 2025
Not stated Not stated Not stated Not reported
Thomas Sandgaard Also a director
Chief Executive Officer
66 Not stated Not stated $991,810
Vikram Singh Bajaj
Chief Financial Officer
Title from the Form 3 dated Aug 18, 2025
Not stated Not stated Not stated Not reported
Daniel J Moorhead
CHIEF FINANCIAL OFFICER
Title from the Form 4 dated Jun 5, 2025
Not stated Not stated Not stated $909,805
Anna Lucsok
CHIEF OPERATING OFFICER
Title from the Form 4 dated Jul 27, 2025
Not stated Not stated Not stated $709,109
John T Bibb
Chief Legal Officer
Title from the Form 3 dated Aug 18, 2025
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
4
serving now
Independent
Not stated
the proxy does not say
Average tenure
12.5 years
from year joined
CEO also chairs the board
Yes
Thomas Sandgaard
Director Age On board Independent Committees Other public boards 2024 pay Source
Thomas Sandgaard
66 1996
29 years
Not stated None stated None stated Paid as CEO
Barry D. Michaels
75 2018
7 years
Not stated
Audit Committee · Chair Compensation Committee Nominating and Governance Committee
None stated $175,000
Michael Cress
67 2018
7 years
Not stated
Compensation Committee · Chair Audit Committee Nominating and Governance Committee
None stated $170,000
Joshua R. Disbrow
50 2018
7 years
Not stated
Nominating and Governance Committee · Chair Audit Committee Compensation Committee
Aytu BioPharma $170,000

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 28, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support